Table 2.
Outcome | Model | β-Coefficient | 95% CI | P Value |
---|---|---|---|---|
Hip BMD, g/cm2 | 1 | 0.48 | 0.28, 0.67 | <.01 |
2 | 0.29 | 0.07, 0.51 | .01 | |
Cortical area, mm2 | 1 | 0.38 | 0.23, 0.53 | <.01 |
2 | 0.29 | 0.11, 0.46 | <.01 | |
Cortical BMD, mg/cm3 | 1 | 0.23 | −0.06, 0.51 | .12 |
2 | 0.39 | 0.06, 0.73 | .02 | |
ECPC, mm | 1 | −0.32 | −0.46, −0.18 | <.01 |
2 | −0.24 | −0.40, −0.08 | <.01 | |
Total bone area, mm2 | 1 | 0.18 | (0.01, 0.36 | .04 |
2 | 0.10 | −0.10, 0.30 | .33 | |
Cortical to total bone area ratio, % | 1 | 0.29 | 0.03, 0.56 | .03 |
2 | 0.26 | −0.06, 0.57 | .11 | |
Tibial SSI, mm3 | 1 | 0.34 | 0.18, 0.49 | <.01 |
2 | 0.26 | 0.09, 0.44 | <.01 |
All outcome and exposure variables were standardized. Standardized β-coefficients represent SD change in outcome per SD change in exposure (log 2-legged jump power). Model 1 was adjusted for age, gender, and height. Model 2 was adjusted for age, gender, height, and weight (as quadratic term). For hip BMD, n = 189; for all other other outcomes, n = 113.